A phase II study of KZR-616 in immune thrombocytopenia (ITP)
Latest Information Update: 13 Jun 2019
At a glance
- Drugs Zetomipzomib (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
Most Recent Events
- 13 Jun 2019 New trial record
- 10 Jun 2019 According to a Kezar Life Sciences media release, the company expects to commence this study in the second half of 2019.